Skip to content
Menu

Adaptive Biotechnologies Corporation ADPT

Full chart Compare
Set alert

Price alert · ADPT

All alert types
28.06 USD -0.98 (-3.36%)

As ofNov 16, 2026, 11:06 AM EST

27.29 Day range 28.52
12.00 52-week range 32.21
YTD
+72.80%
1 year
+99.03%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$205.62MNet Loss$59.50MCost of Revenue$71.36MExpenses$265.12MSelling, General & Admin$167.27MResearch & Development$93.77MOther Operating Expenses$1.70MOther Expenses$2.38MRevenue$276.98M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ADPT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
276.98M178.96M170.28M185.31M154.34M
205.62M106.88M94.72M127.40M105.04M
-57.12M-162.55M-227.03M-200.19M-208.97M
-59.50M-159.49M-225.25M-200.19M-207.28M
-0.39-1.08-1.56-1.40-1.48
ADPT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
73.18M50.82M68.00M92.43M141.20M
512.74M539.38M661.13M856.62M923.34M
287.74M336.89M352.86M392.52M319.24M
210.36M222.67M229.43M233.36M111.74M
218.79M202.71M308.40M464.17M603.99M
ADPT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-45.99M-95.21M-156.32M-183.94M-192.73M
37.95M77.79M129.65M2.90M181.21M
30.40M241.00K2.25M132.26M27.15M
-2.96M-3.66M-10.70M-16.35M-61.75M
22.37M-17.18M-24.43M-48.77M15.63M